Introduction: Advances and Issues in NSCLC

Panelists: David R. Gandara, MD, UC Davis; Corey J. Langer, MD, Penn Medicine;
Alan B. Sandler, MD, OHSU; Mark A. Socinski, MD, University of Pittsburgh;
Anne S. Tsao, MD, MD Anderson
Published Online: Tuesday, January 22, 2013
For High-Definition, Click
In the first installment of the series, the moderator, David R. Gandara, MD, provides an overview of the topics that will be discussed by the panel, which includes: Corey J. Langer, MD, Alan B. Sandler, MD, Mark A. Socinski, MD, and Anne S. Tsao, MD.

Gandara notes that this Peer Exchange discussion will focus on a range of issues and challanges facing physicians who treat patients with lung cancer. Specifically, the panel will examine new therapies and testing for molecular abnormalities and the integration of these test results into the treatment decision making process.
View More From This Discussion
Episode 1 Introduction: Advances and Issues in NSCLC
Episode 2 Best Practices in NSCLC Molecular Testing, Part I
Episode 3 Best Practices in NSCLC Molecular Testing, Part II
Episode 4 Molecular Testing and Actionable Targets in NSCLC
Episode 5 Concurrent Versus Sequential Testing in NSCLC
Episode 6 Rebiopsying and Molecular Testing in NSCLC
Episode 7 Selecting a Laboratory for Molecular Testing in NSCLC
Episode 8 Selecting Treatment for First- Line Non-Squamous NSCLC
Episode 9 Squamous Cell Carcinoma Treatment Options
Episode 10 Molecular Heterogeneity in Non-Small Cell Lung Cancer
Episode 11 Promising Emerging Classes of Therapies in NSCLC
Episode 12 Access to Molecular Testing Therapy in NSCLC
Episode 13 Personalizing the Treatment of Lung Cancer
Episode 14 Impact of EGFR Mutations on Treatment Decisions in NSCLC
Episode 15 The Cost-Effectiveness of Targeted Therapies in NSCLC
Expert Panelists
 David R. Gandara

David R. Gandara, MD

Moderator
Director, Thoracic Oncology Program,
University of California, Davis Comprehensive Cancer Center
Sacramento, California
 

Corey J. Langer, MD

Director, Thoracic Oncology, The University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania

Alan B. Sandler, MD

Professor of Medicine in Hematology & Oncology, Oregon Health & Science University, Portland, Oregon
 

Mark A. Socinski, MD

Director, Lung Cancer Section, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania

Anne S. Tsao, MD

Director, Mesothelioma Program, The University of Texas MD Anderson Comprehensive Cancer Center
Houston, Texas
Online CME Activities
Free CME from PER
Community Practice Connections: 13th Annual International Congress on the Future of Breast Cancer®
Highlights From the 13th Annual International Congress on the Future of Breast Cancer®
Pancreatic Cancer: Novel and Emerging Approaches to Early Detection and Treatment
Oncology Best Practice: Challenges in Treating Chronic Lymphocytic Leukemia – The Older Patient and Comorbid Conditions
The content contained in this video is for general information purposes only. The viewer is encouraged to confirm the information presented with other sources. OncLiveTV Peer Exchange makes no representations or warranties of any kind about the completeness, accuracy, timeliness, reliability, or suitability of any of the information, including content or advertisements, contained in this video and expressly disclaims liability for any errors and omissions that may be presented in this video. OncLiveTV Peer Exchange reserves the right to alter or correct any error or omission in the information it provides in this video, without any obligations. OncLiveTV Peer Exchange further disclaims any and all liability for any direct, indirect, consequential, special, exemplary, or other damages arising from the use or misuse of any material or information presented in this video. The views expressed in this video are those of the panelists and do not necessarily reflect the opinion or policy of OncLiveTV Peer Exchange.
 
More Reading
Publications
$auto_registration$